The experiments described in this paper were designed
The first studies investigating the mechanism of preand performed between 1991 and 1992 when I was in the conditioning-induced protection were reported by Downey final year of my Ph.D studentship. I was introduced to and colleagues in 1990 [3, 4] . Liu et al. [5] reported that a preconditioning at my first American Heart Association 5-min intracoronary infusion of adenosine was as effective meeting in 1989 and was fascinated that evolution had as 5 min of ischaemia in protecting parabiotically perfused devised an endogenous protective mechanism for the heart, isolated hearts against infarction from a 45-min ischaemic which was far more effective than any intervention deinsult. Similarly an infusion of the A -selective agonist 1 6 veloped by man. Not surprising really, considering that N -1-(phenyl-2R-isopropyl) adenosine limited infarction at evolution has been working on stress adaptation for a a dose which had no vasodilatory activity. Furthermore, couple of a million years! Since the aim of my PhD project blockade of A -receptors with 8-SPT abolished protection. 1 was to extend the window of preservation for donor hearts Similar results had also been reported in abstract form in prior to transplantation, after the AHA meeting, I began the pig [6] and dog [7] again using cell necrosis as an experiments to explore whether ischaemic preconditioning end-point of protection. None of these studies had investicould provide protection over and above that provided by gated the impact of pharmacological preconditioning cardioplegia.
against contractile dysfunction nor had they demonstrated For the transplanted heart, we felt the most important the involvement of adenosine in the mechanism of preparameter for assessment was contractile function. For a conditioning in the rat. heart to be weaned off cardiopulmonary bypass, contractile Therefore our studies were designed to investigate function must recover sufficiently to support the body. It whether a 5-min infusion of adenosine, at three different would be somewhat irrelevant for the transplanted heart if doses (10, 50 and 100 mmol / l), could mimic the protecpreconditioning reduced cell necrosis but left the heart so tion provided by 5 min of ischaemia in the isolated stunned that it could not maintain a sufficient cardiac working rat heart. All three doses resulted in a profound output. However, in 1989, there were no published studies chronotropic effect and therefore hearts were paced specifically investigating preconditioning-induced protecthroughout these protocols. The results clearly demontion against contractile dysfunction. Therefore, my initial strated that when compared to a control infusion of saline, work characterised the phenomenon of preconditioning none of the doses of adenosine provided any additional using the isolated ejecting rat heart and contractile function protection in terms of protection against contractile as the end-point of assessment [1] before proceeding to dysfunction. However, there was some evidence of protecinvestigate whether preconditioning could improve on the tion against cell necrosis as creatine kinase release was protection provided by cardioplegia [2] . Since subjecting a significantly reduced at the highest dose of adenosine (100 donor heart to additional ischaemia, however short, is mmol / l). Since it was possible that exogenously supplied clearly not ideal, an obvious extension to these studies was adenosine had different effects to endogenously produced to examine the possibility that the protection provided by adenosine, we extended the study to determine whether ischaemic preconditioning could be mimicked by pharma-8-SPT could block ischaemic preconditioning in this cological means. model. A dose of 8-SPT was chosen (10 mmol / l) which blocked the negative chronotropic effect of exogenously supplied adenosine without effect on pre-ischaemic con- ence of 8-SPT depressed functional recovery in both the [10] subsequently demonstrated that stimulation of a -1 preconditioned and control group but these differences did adrenergic receptors was primarily involved in the initianot reach a level of significance (Fig. 1) . We therefore tion of preconditioning in the rat. concluded that while there was evidence that adenosine Several years on, the preconditioning picture with regard could be protective in the rat [8], adenosine release did not to the initiation of preconditioning is clearer. We now appear to be primarily involved in the mechanism of know that several agonists are able to initiate protection preconditioning against contractile function. and the relative contributions of each of the agonists will The results with adenosine were initially presented in vary among species and models. The rat as a species is not abstract form at the 1991 International Society for Heart dependent upon adenosine as an initiator but despite this it Research in Cincinnati, Ohio, USA. Presentation of these is clear that the phenomenon is effective in this species. results met with considerable opposition and I clearly
The controversy still continues as to which of the three remember having to defend the results and conclusions to a endpoints of assessment are most relevant and whether the packed and skeptical auditorium. The main criticism was same mechanism of action exists for each of the different that I had failed to show in my model that adenosine itself end-points. It is probably fair to say that infarct size as an was protective when given as a pre-treatment without end-point of assessment is the 'gold standard' and that the washout. I argued then, and still do, that such results would assessment of preconditioning-induced protection against be irrelevant as an intervening washout period was essencontractile dysfunction is likely to represent a combination tial in order to fully mimic preconditioning. More support of protection against cell death and stunning. However, for our hypothesis came the following year when Liu and having said this, assessment of infarct size can be compliDowney [9] demonstrated that the adenosine antagonist cated by the choice of staining [11] and the degree of PD115,199 failed to block preconditioning-induced proteccollateral flow. tion against cell necrosis in the rat. Although this group
In conclusion, 13 years after the first paper on precondicould produce protection against infarct size with an tioning was published [12] and despite intense research 6 intracoronary infusion of an A -agonist (2-chloro-Nactivity, the end-effector of preconditioning-induced 1 cyclopentyladenosine), they concluded that adenosine was protection still eludes us. We can take small comfort from not an initiator of preconditioning in the rat. Banerjee et al.
the fact that we have worked out how preconditioning is initiated and that, pharmacologically, we can mimic it, but it is clear that, as we enter the new Millennium, evolution still holds a few tricks up her sleeve! 
